A Unicorn
Years Experience
in Nano Technology Design
NanoSense Ltd specializes in advanced optical sensors for detecting volatile organic compounds (VOCs), semi-volatile organic compounds (SVOCs), and viruses. Our sensors offer immediate insights, crucial for timely diagnostics, enhancing safety across diverse markets including healthcare, aviation, public safety, environmental monitoring, and Military NBC detection.
Learn More
NanoSense is seeking £14.1 million funding to accelerate our growth and capitalise on the significant market opportunity ahead. The investment will be allocated to:
Product Pilot Build World Class Labs Ensure Production Continuity Research, Development Testing Develop Strategic Partnerships We project a strong financial outlook. With the rising demand in the optical sensor market, we anticipate significant revenue growth, driven by sales, licensing, and service contracts. Our financial strategy includes reinvesting a portion of profits into R&D to fuel continuous innovation. We foresee a steady increase in market share and profitability as our technology gains wider acceptance across various sectors. This growth, coupled with strategic investments and expansions, positions us for sustained financial success in the upcoming years.
Volatile Organic Compounds (VOCs) and Semi-Volatile Organic Compounds (SVOCs) sensors are designed to detect the presence of these specific compounds in the environment.
A disruptive technoligy that changes how we sense / detect compounds at a molecular level in ‘real - time’
Semi Volatile and Volatile Organic Compound detection
Selectively detecting SVOC’s VOC’s & Viruses in : aircraft, breath samples, internal and external environments.
Platfrom technology for adaptation across multiple markets for personal, clinical and industrial use.
Our Sensors integrate seamlessly into various settings, from hospitals to aircraft to environmental monitoring stations, providing on the sport analysis without the need for bulky equipment or lab facilities they have the unique ability to detect multiple poisonous compounds individually
The Sensor software analyses the sensor signals and determines the compound
If appropriate , an alarm is triggered with the compound identified displayed
The Compound enters the coating “sponge” and an optical interference pattern is created
Nano optical sensors and mass spectrometry units are both instrumental in detecting and analyzing substances, but they operate on different principles and serve distinct purposes.
A handheld sensor for instant, precise compound detection that :
Innovator with extensive experience in optical, mechanical, electronic engineering and healthcare technology.
Nanotechnology expert, driving force behind our sensor tech development.
Aerospace specialist advancing environmental safety through product innovation.
Seasoned in steering operations and sales to align products & services with market needs.
Steven is a Chartered Accountant and Fellow of the Institute of Chartered Accountants in England and Wales. Steven manages tax and finance for the NanoSense Group of Companies.
Expert in strategy and business development at startups, scaleups, and enterprises in 35 countries. Hands-on international experience. A former consultant with top-tier firm Booz Allen Hamilton.
The bipartisan Federal Aviation Administration reauthorization is a big win for travelers, the aviation workforce, and our economy. It will expand critical protections for air travelers, strengthen safety standards, and support pilots, flight attendants, and air traffic controllers. It also builds on my Administration’s efforts to improve the travel experience for airline passengers, affirming the Department… Continue reading Statement from President Joe Biden After Signing FAA Reauthorization Act
Read MorePublished on: 25 Apr 2024, under Press Releases Cambridge, UK, April 25, 2024: Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation (“the Gates Foundation” or “the foundation”). The funding is comprised of a… Continue reading Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease
Read MorePublished on: 9 Nov 2023, under Science & Research Cambridge, UK, November 9, 2023: Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a peer-reviewed study in the journal Biomedicines – ‘Exogenous Volatile Organic Compound (EVOC®) Breath Testing Maximizes Classification Performance for Subjects with Cirrhosis… Continue reading Owlstone Medical Publishes Exciting Liver Data on the use of an EVOC® Probe for the Early Detection of Cirrhosis
Read More
Cabin Air Sensor Solutions Ltd, (CASS) announced today that they had successfully completed their 9-month compound sensing work package adding Ethanol, Ammonia, Acetone, Toluene, Tricresyl Phosphate & Carbon Monoxide to their compound detection capability.
Read More
